- JP-listed companies
- 3-D Matrix,Ltd.
- Financials
- Research & development
3-D Matrix,Ltd. (7777)
Market cap
¥50.7B
P/E ratio
54.9x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
| Period End | Research & development (Million JPY) | YoY (%) |
|---|